JPMorgan’s Sharp Reversal… And The Latest Entry To The Weight Loss Drug Battle 5/20/24

Shares of JPMorgan losing steam in the session after CEO Jamie Dimon’s comments on owning the bank, and his own succession plans. Where the financial heavyweight is heading next. Plus Telehealth provider Hims & Hers surging after announcing it will offer GLP-1 injections. How they’re hoping to tip the scales in the obesity drug wars. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.